Correlation Between Lyell Immunopharma and Crinetics Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Lyell Immunopharma and Crinetics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyell Immunopharma and Crinetics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyell Immunopharma and Crinetics Pharmaceuticals, you can compare the effects of market volatilities on Lyell Immunopharma and Crinetics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyell Immunopharma with a short position of Crinetics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyell Immunopharma and Crinetics Pharmaceuticals.
Diversification Opportunities for Lyell Immunopharma and Crinetics Pharmaceuticals
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Lyell and Crinetics is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Lyell Immunopharma and Crinetics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crinetics Pharmaceuticals and Lyell Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyell Immunopharma are associated (or correlated) with Crinetics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crinetics Pharmaceuticals has no effect on the direction of Lyell Immunopharma i.e., Lyell Immunopharma and Crinetics Pharmaceuticals go up and down completely randomly.
Pair Corralation between Lyell Immunopharma and Crinetics Pharmaceuticals
Given the investment horizon of 90 days Lyell Immunopharma is expected to under-perform the Crinetics Pharmaceuticals. In addition to that, Lyell Immunopharma is 1.47 times more volatile than Crinetics Pharmaceuticals. It trades about -0.01 of its total potential returns per unit of risk. Crinetics Pharmaceuticals is currently generating about 0.08 per unit of volatility. If you would invest 1,626 in Crinetics Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of 4,141 from holding Crinetics Pharmaceuticals or generate 254.67% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Lyell Immunopharma vs. Crinetics Pharmaceuticals
Performance |
Timeline |
Lyell Immunopharma |
Crinetics Pharmaceuticals |
Lyell Immunopharma and Crinetics Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Lyell Immunopharma and Crinetics Pharmaceuticals
The main advantage of trading using opposite Lyell Immunopharma and Crinetics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyell Immunopharma position performs unexpectedly, Crinetics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crinetics Pharmaceuticals will offset losses from the drop in Crinetics Pharmaceuticals' long position.Lyell Immunopharma vs. Cullinan Oncology LLC | Lyell Immunopharma vs. Monte Rosa Therapeutics | Lyell Immunopharma vs. Revolution Medicines | Lyell Immunopharma vs. Nkarta Inc |
Crinetics Pharmaceuticals vs. Ikena Oncology | Crinetics Pharmaceuticals vs. Eliem Therapeutics | Crinetics Pharmaceuticals vs. HCW Biologics | Crinetics Pharmaceuticals vs. RenovoRx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Fundamental Analysis View fundamental data based on most recent published financial statements |